203 related articles for article (PubMed ID: 16286050)
1. Comparative performance evaluation of the HIV-1 LiPA protease and reverse transcriptase resistance assay on clinical isolates.
Tsongalis GJ; Gleeson T; Rodina M; Anamani D; Ross J; Joanisse I; Tanimoto L; Ziermann R
J Clin Virol; 2005 Dec; 34(4):268-71. PubMed ID: 16286050
[TBL] [Abstract][Full Text] [Related]
2. Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy.
Servais J; Lambert C; Fontaine E; Plesséria JM; Robert I; Arendt V; Staub T; Schneider F; Hemmer R; Burtonboy G; Schmit JC
J Clin Microbiol; 2001 Feb; 39(2):454-9. PubMed ID: 11158089
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus 1 strains resistant to nucleoside inhibitors of reverse transcriptase in isolates from the Czech Republic as monitored by line probe assay and nucleotide sequencing.
Reinis M; Vandasová J; Stanková M; Linka M; Brůcková M
Acta Virol; 2001; 45(5-6):279-86. PubMed ID: 12083326
[TBL] [Abstract][Full Text] [Related]
4. Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.
Muñoz M; Carmona R; Pérez-Alvarez L; Cilla G; Suarez MD; Delgado E; Contreras G; Corral J; de Goicoetxea MJ; Medrano L; Lezaún MJ; Nájera R;
J Clin Virol; 2005 Jul; 33(3):224-9. PubMed ID: 15911444
[TBL] [Abstract][Full Text] [Related]
5. Rapid detection of drug resistant HIV -1 to reverse transcriptase and protease inhibitors in HIV-infected patients receiving highly active antiretroviral therapies.
Yu M; Kabat W; Wang J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):325-9. PubMed ID: 11471017
[TBL] [Abstract][Full Text] [Related]
6. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.
Buckton AJ; Bissett SL; Myers RE; Beddows S; Edwards S; Cane PA; Pillay D
J Antimicrob Chemother; 2008 Dec; 62(6):1191-8. PubMed ID: 18927229
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of three human immunodeficiency virus genotyping systems: the HIV-GenotypR method, the HIV PRT GeneChip assay, and the HIV-1 RT line probe assay.
Wilson JW; Bean P; Robins T; Graziano F; Persing DH
J Clin Microbiol; 2000 Aug; 38(8):3022-8. PubMed ID: 10921971
[TBL] [Abstract][Full Text] [Related]
8. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
[TBL] [Abstract][Full Text] [Related]
9. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
[TBL] [Abstract][Full Text] [Related]
10. [Evaluating the therapeutic care of HIV infection in Tunisia].
Jlizi A; Slim A; Benammar Elgaaied A; Ben Rejab S; Ben Chaabane T; Letaief-Omezzine A; Chakroun M; Garbouj M
Tunis Med; 2008 Jun; 86(6):534-9. PubMed ID: 19216443
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 nucleotide mixture detection in the virco(®)TYPE HIV-1 genotyping assay: a comparison between Sanger sequencing and 454 pyrosequencing.
De Wolf H; Van Marck H; Mostmans W; Thys K; Vandenbroucke I; Van Eygen V; Pattery T; Verhasselt P; Aerssens J
J Virol Methods; 2011 Jul; 175(1):129-32. PubMed ID: 21549149
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of three genotyping methods for the detection of HIV-1 resistance to antiretroviral drugs].
Suárez A; Picazo J; Alonso R; Bouza E; Delgado R; Rodríguez-Noriega A; Bernal A; García A
Rev Esp Quimioter; 2002 Mar; 15(1):43-48. PubMed ID: 12582436
[TBL] [Abstract][Full Text] [Related]
13. Development and performance of conventional HIV-1 phenotyping (Antivirogram®) and genotype-based calculated phenotyping assay (virco®TYPE HIV-1) on protease and reverse transcriptase genes to evaluate drug resistance.
Pattery T; Verlinden Y; De Wolf H; Nauwelaers D; Van Baelen K; Van Houtte M; Mc Kenna P; Villacian J
Intervirology; 2012; 55(2):138-46. PubMed ID: 22286884
[TBL] [Abstract][Full Text] [Related]
14. Profile of drug resistance mutations among HIV-1-infected Tunisian subjects failing antiretroviral therapy.
Jlizi A; Ben Ammar El Gaaied A; Slim A; Tebourski F; Ben Mamou M; Ben Chaabane T; Letaief-Omezzine A; Chakroun M; Garbouj M; Ben Rejeb S
Arch Virol; 2008; 153(6):1103-8. PubMed ID: 18483694
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.
Babic DZ; Zelnikar M; Seme K; Vandamme AM; Snoeck J; Tomazic J; Vidmar L; Karner P; Poljak M
Virus Res; 2006 Jun; 118(1-2):156-63. PubMed ID: 16417938
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of antiretroviral HIV treatment success based on medical history or guided by the reverse hybridisation LiPA HIV genotyping system.
Alvarez M; García F; Martínez NM; Hernández Quero J; Louwagie J; De Brauwer A; Maroto MC
J Med Virol; 2004 Jun; 73(2):151-7. PubMed ID: 15122786
[TBL] [Abstract][Full Text] [Related]
17. Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients.
Bon I; Gibellini D; Borderi M; Alessandrini F; Vitone F; Schiavone P; Re MC
J Clin Virol; 2007 Apr; 38(4):313-20. PubMed ID: 17306618
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes.
Aitken SC; Kliphuis A; Wallis CL; Chu ML; Fillekes Q; Barth R; Stevens W; Rinke de Wit TF; Schuurman R
J Clin Virol; 2012 May; 54(1):21-5. PubMed ID: 22306272
[TBL] [Abstract][Full Text] [Related]
19. Performance evaluation of the two protease sequencing primers of the Trugene HIV-1 genotyping kit.
Ribas SG; Heyndrickx L; Ondoa P; Fransen K
J Virol Methods; 2006 Aug; 135(2):137-42. PubMed ID: 16777242
[TBL] [Abstract][Full Text] [Related]
20. Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naïve HIV-1 patients with acute and chronic infection.
Re MC; Monari P; Bon I; Borderi M; Chiodo F;
Int J Antimicrob Agents; 2004 Feb; 23(2):164-8. PubMed ID: 15013042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
